Clinical Trials
5 trialsNCT07217938 2026-03-03
TRADstat
Peter MacCallum Cancer Centre, Australia
Phase 2 Recruiting
NCT03556228 2025-12-11
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology, LLC
Phase 1/2 Recruiting
NCT07042711 2025-06-29
Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients
Indonesia University
Phase NA Active not recruiting
NCT03027557 2021-05-25
DENOCINA
Aalborg University Hospital
Phase 3 Completed
NCT01976741 2021-05-06
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
Bayer
Phase 1 Completed